Duopharma Q3 financial results improve


Year-to-date, Duopharma’s net profit rose 17.8% to RM49.97mil from RM42.42mil in the nine months to September 2020, while revenue grew 13.3% to RM493.73mil from RM435.82mil previously.

PETALING JAYA: Duopharma Biotech Bhd’s net profit rose 20% to RM16.93mil for the third quarter ended Sept 30, 2021 (Q3’21) from RM14.13mil in Q3’20 on higher revenue and lower expenditures.

The company’s revenue rose 28.5% to RM171.84mil in Q3’21 from RM133.77mil previously.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Duopharma Biotechprofit , revenue , sales ,

   

Next In Business News

Majuperak, Shizen to explore solar photovoltaic development in Perak
Asia stocks rise, yen plumbs 34-year low as BOJ stands pat on rates
Fernandes: AirAsia Group to be listed on Bursa Malaysia in September
Spritzer clarifies mistaken identity in insider trading report
Berjaya Corp denies involvement in Forest City Casino talks
Malaysia's PPI higher by 1.6% in March 2024
Microlink wins RM56.45mil contract from Bank Islam Brunei
Bursa Malaysia higher at midday in sync with regional peers
PETRONAS, CelcomDigi collaborate on digital transformation and sustainability efforts for the energy industry
Ringgit retreats vs US$ ahead of personal consumption expenditure reading

Others Also Read